Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Copenhagen
Clinical trial register · Denmark

Clinical Trials in Copenhagen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Aalborg 22 Copenhagen 21 Herlev 18 Aarhus N 17 Hvidovre 14
Narrow the registerReset
Recruitment status
Phase
Site location
Aalborg22 Copenhagen21 Herlev18 Aarhus N17 Hvidovre14
All 33 locations
Target enrolment
to

Trials with a site in Copenhagen

22 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Recruiting
AstraZeneca
Phase 3
600
Aarhus, Copenhagen, Gandrup, Herlev, Herning, Svendborg, Vejle, Viborg
2026-08-12
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Aarhus, Copenhagen, Hellerup, Odense C
2026-06-11
Recruiting
Anifrolumab Malignancy and Serious Infections Study
NCT07000110Systemic Lupus Erythematosus
AstraZeneca
Observational
3,506
Copenhagen
2026-01-26
Recruiting
AstraZeneca
Phase 1/2
84
Copenhagen
2026-01-09
Recruiting
Tezspire Cardiac Events PASS
NCT06951867Cardiovascular Events, MACE
AstraZeneca
Observational
16,640
Copenhagen
2025-09-15
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
AstraZeneca
Phase 3
473
Aarhus N, Copenhagen, Esbjerg, Herlev, Herning, Hvidovre, Viborg
2025-06-10
Recruiting
AstraZeneca
Phase 3
15,100
Aarhus N, Copenhagen, Esbjerg, Frederiksberg, Gandrup, Gistrup, Herlev, Herning
2025-06-04
Recruiting
AstraZeneca
Phase 3
11,300
Aarhus, Aarhus N, Copenhagen, Esbjerg, Frederiksberg, Gistrup, Herlev, Herning
2025-03-14
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
AstraZeneca
Phase 1/2
408
Aalborg, Aarhus N, Copenhagen, Odense C
2025-01-30
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
AstraZeneca
Phase 2
270
Aalborg, Copenhagen, Vejle
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,018
Aalborg, Copenhagen, Odense C, Roskilde
2024-08-07
Active, closed
AstraZeneca
Phase 3
339
Aarhus, Copenhagen
2024-06-29
Active, closed
AstraZeneca
Phase 3
863
Aarhus N, Copenhagen
2023-11-09
Recruiting
AstraZeneca
Phase 3
3,527
Aalborg, Aarhus N, Copenhagen, Copenhagen Ø, Herning, Hillerød, Hvidovre, Kolding
2022-12-13
Active, closed
AstraZeneca
Phase 1/2
212
Copenhagen
2021-09-14
Active, closed
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
NCT04639219Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
AstraZeneca
Phase 2
102
Copenhagen
2020-12-30
Active, closed
AstraZeneca
Phase 3
866
Aalborg, Copenhagen Ø, Odense, Vejle
2020-07-24
Active, closed
AstraZeneca
Phase 4
75
Aalborg, Aarhus N, Copenhagen, Hvidovre, Næstved, Odense C, Vejle
2019-10-08
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/copenhagen

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 22 of those studies with a site in Copenhagen that also match the filters currently applied.

How many clinical trials are recruiting in Copenhagen?

13 of the 22 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 9 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Copenhagen), 22 studies
PhaseStudiesRecruitingShare
Phase 312654.5%
Observational3313.6%
Phase 1/23213.6%
Phase 23213.6%
Phase 4104.5%

Most active sponsors

Lead sponsors with the most studies (Copenhagen)
Lead sponsorStudiesRecruiting
AstraZeneca2213
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.